Intuitive Surgical (ISRG) Misses Q1 EPS by 9c, Slight Beat on Revenues
Get Alerts ISRG Hot Sheet
Price: $372.63 -0.41%
Revenue Growth %: +11.2%
Financial Fact:
Gross profit: 487M
Today's EPS Names:
ESCA, LICT, NKSH, More
Revenue Growth %: +11.2%
Financial Fact:
Gross profit: 487M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Intuitive Surgical (NASDAQ: ISRG) reported Q1 EPS of $2.61, $0.09 worse than the analyst estimate of $2.70. Revenue for the quarter came in at $973.7 million versus the consensus estimate of $973.43 million.
- Worldwide da Vinci procedures grew approximately 18% compared with the first quarter of 2018, driven primarily by growth in U.S. general surgery procedures and worldwide urologic procedures.
- The Company shipped 235 da Vinci Surgical Systems, an increase of 27% compared with 185 in the first quarter of 2018.
- The Company grew its installed base to 5,114 systems as of March 31, 2019, an increase of 13% compared with 4,528 as of the end of the first quarter of 2018.
- First quarter 2019 revenue of $974 million grew approximately 15% compared with $848 million for the first quarter of 2018.
- First quarter 2019 GAAP net income was $307 million, or $2.56 per diluted share, compared with $288 million, or $2.44 per diluted share, for the first quarter of 2018.
- First quarter 2019 non-GAAP* net income was $312 million, or $2.61 per diluted share, compared with $288 million, or $2.44 per diluted share, for the first quarter of 2018.
- In February 2019, the Company received U.S. Food and Drug Administration (“FDA”) clearance for the IonTM endoluminal system, the Company’s new flexible robotic-assisted catheter-based platform, designed to navigate through very small lung airways to reach peripheral nodules for biopsies.
- In February 2019, the Company received FDA clearance for the IRISTM augmented reality product, designed to aid surgeons in both pre- and intra-operative settings by delivering a 3D image of the patient anatomy.
- In March 2019, the Company received FDA clearance for the da Vinci SP® Surgical System for use in certain transoral otolaryngology procedures in adults.
For earnings history and earnings-related data on Intuitive Surgical (ISRG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuitive Surgiical (ISRG) beats earnings, revenue expectations in Q1
- United Bancshares, Inc. (UBOH) Reports Q1 EPS of $0.61
- SB Financial Group (SBFG) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
Earnings, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!